Abbott Laboratories (XSWX:ABT) Total Payout Ratio: 0.79 (As of Jul. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:ABT Abbott Laboratories XSWX:ABT
70 GF Score
Price CHF73.00
GF Value CHF106.67
! 1 Warning Sign
View Full Analysis

What is Abbott Laboratories Total Payout Ratio?

Abbott Laboratories XSWX:ABT -5.81% 70 Total Payout Ratio is 0.79 as of Jul. 16, 2026. GuruFocus rates XSWX:ABT with a GF Score™ of 70/100 and a GF Value™ of CHF106.67. The stock has 1 warning sign investors should review.

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Abbott Laboratories's current Total Payout Ratio is 0.79.

Abbott Laboratories Total Payout Ratio Related Terms

Abbott Laboratories Total Payout Ratio Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Total Payout Ratio Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 1.03 0.84 0.38 0.77

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.99 0.58 0.81 0.75 1.19

XSWX:ABT vs SYK, MDT, BSX: Total Payout Ratio Comparison

For the Medical Devices subindustry, Abbott Laboratories's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott Laboratories Total Payout Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's Total Payout Ratio falls into.


XSWX:ABT
70GF Score
Abbott Laboratories XSWX:ABT
Total Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Abbott Laboratories's Total Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-711.632 + 0 + -3280.04) / 5198.976
=0.77

Abbott Laboratories's Total Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-141.714 + 0 + -864.455) / 847.922
=1.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Payout Ratio →
What does a Total Payout Ratio of 0.79 mean?
Abbott Laboratories (XSWX:ABT) has a Total Payout Ratio of 0.79 as of Jul. 16, 2026. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Total Payout Ratio too high?
Abbott Laboratories' current Total Payout Ratio is 0.79. Overall, Abbott Laboratories has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Total Payout Ratio compare to SYK and MDT?
Abbott Laboratories' Total Payout Ratio of 0.79 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Payout Ratio for a Medical Devices & Instruments company?
A good Total Payout Ratio depends on the Medical Devices & Instruments industry context. However, Total Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Payout Ratio mean?
A high Total Payout Ratio can signal that a stock is expensive relative to its fundamentals. Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Total Payout Ratio is 0.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current Total Payout Ratio of 0.79. The stock's GF Value™ is CHF106.67, compared to a current price of CHF73.00 — trading 31.6% below its estimated fair value. The current Total Payout Ratio is 0.79. Abbott Laboratories' overall GF Score™ is 70/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Payout Ratio calculated?
Total Payout Ratio is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current Total Payout Ratio is 0.79 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF73.00 is trading 31.6% below its estimated GF Value™ of CHF106.67.

Key valuation signals for XSWX:ABT:

  • Total Payout Ratio: 0.79
  • GF Value™: CHF106.67 vs. price of CHF73.00 (31.6% below fair value)
  • GF Score™: 70/100 with 1 warning sign

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
70GF Score

Get the complete analysis for XSWX:ABT

Total Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF73.00
Price
CHF106.67
GF Value